Patent details

Basic Information

Publication number:

EP1214409

PCT Application Number:

PCT/US/2000/006471

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP009178781

PCT Publication Number:

WO/2001/018210

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FIBROBLAST GROWTH FACTOR-19 (FGF-19) NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE FOR THE TREATMENT OF OBESITY

French Title of Invention:

ACIDES NUCLEIQUES ET POLYPEPTIDES DU FACTEUR 19 DE CROISSANCE DU FIBROBLASTE, ET PROCEDES D'UTILISATION DANS LE TRAITEMENT DE L'OBESITE

German Title of Invention:

FIBROBLASTEN-WACHSTUMSFAKTOR-19 (FGF-19) NUKLEINSÄURE UND POLYPEPTIDE UND VERFAHREN ZU DEREN VERWENDUNG FÜR BEHANDLUNG VON FETTLEIBIGKEIT

SPC Number:

Dates

Filing date:

09/03/2000

Grant date:

17/05/2006

EP Publication Date:

17/05/2006

PCT Publication Date:

15/03/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/06/2002

EP B1 Publication Date:

17/05/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/03/2019

Expiration date:

09/03/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/03/2000

 

 

Name:

GENENTECH INC.

Address:

1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

05/07/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

STEWART Timothy, A.

Address:

United States (US)

2

Name:

TOMLINSON Elizabeth

Address:

United States (US)

Priority

1

Priority Number:

20594

Priority Date:

08/09/1999

Priority Country:

United States (US)

2

Priority Number:

21090

Priority Date:

15/09/1999

Priority Country:

United States (US)

3

Priority Number:

30999

Priority Date:

20/12/1999

Priority Country:

United States (US)

4

Priority Number:

04414

Priority Date:

22/02/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 15/12;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

08/03/2018

Last Annual Fee Paid Number:

19

Last Annual Fee Paid Amount:

281 Euro

Payer:

MDC (HENKEL PATENT)

Filing date	Document type	Number of pages